Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

168 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Spesolimab, an anti-interleukin-36 receptor antibody, in patients with moderate-to-severe atopic dermatitis: Results from a multicentre, randomized, double-blind, placebo-controlled, phase IIa study.
Bissonnette R, Abramovits W, Saint-Cyr Proulx É, Lee P, Guttman-Yassky E, Zovko E, Sigmund R, Willcox J, Bieber T. Bissonnette R, et al. Among authors: abramovits w. J Eur Acad Dermatol Venereol. 2023 Mar;37(3):549-557. doi: 10.1111/jdv.18727. Epub 2023 Jan 4. J Eur Acad Dermatol Venereol. 2023. PMID: 36376738 Clinical Trial.
Light-emitting diode-based therapy.
Abramovits W, Arrazola P, Gupta AK. Abramovits W, et al. Skinmed. 2005 Jan-Feb;4(1):38-41. doi: 10.1111/j.1540-9740.2005.03959.x. Skinmed. 2005. PMID: 15654163 Review. No abstract available.
LidoWorx (4% lidocaine) gel.
Abramovits W, Morrell P, Gupta AK. Abramovits W, et al. Skinmed. 2010 Mar-Apr;8(2):93-4. Skinmed. 2010. PMID: 20527140 No abstract available.
YCANTHTM (Cantharidin) Topical Solution.
Gupta AK, Mann A, Vincent K, Abramovits W. Gupta AK, et al. Among authors: abramovits w. Skinmed. 2023 Nov 10;21(5):360-363. eCollection 2023. Skinmed. 2023. PMID: 37945366 Clinical Trial.
168 results